[go: up one dir, main page]

ES2038643T3 - Procedimiento para la obtencion de una composicion farmaceutica topica. - Google Patents

Procedimiento para la obtencion de una composicion farmaceutica topica.

Info

Publication number
ES2038643T3
ES2038643T3 ES198787114368T ES87114368T ES2038643T3 ES 2038643 T3 ES2038643 T3 ES 2038643T3 ES 198787114368 T ES198787114368 T ES 198787114368T ES 87114368 T ES87114368 T ES 87114368T ES 2038643 T3 ES2038643 T3 ES 2038643T3
Authority
ES
Spain
Prior art keywords
procedure
obtaining
pharmaceutical composition
topic
topic pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787114368T
Other languages
English (en)
Inventor
Farah Joseph Munayyer
Joel August Sequeira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2038643T3 publication Critical patent/ES2038643T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Semiconductor Memories (AREA)
  • Insulated Gate Type Field-Effect Transistor (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SE REFIERE A UNA FORMULACION DE POMADA ELEGANTE, ESTABLE Y AUTO-CONSERVADA QUE CONTIENE FUROATO DE MOMETASONA, 9-ALFA, 21-DICLORO-16ALFA-METIL-1,4-PREGNADIEN11BETA, 17ALFA-DIOL-3,20-DIONA-17-(2''-FUROATO) UTIL COMO PRODUCTO ANTIINFLAMATORIO PARA USO TOPICO.
ES198787114368T 1986-10-02 1987-10-01 Procedimiento para la obtencion de una composicion farmaceutica topica. Expired - Lifetime ES2038643T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/914,227 US4808610A (en) 1986-10-02 1986-10-02 Mometasone furoate anti-inflammatory cream composition using hexylene glycol

Publications (1)

Publication Number Publication Date
ES2038643T3 true ES2038643T3 (es) 1993-08-01

Family

ID=25434063

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787114368T Expired - Lifetime ES2038643T3 (es) 1986-10-02 1987-10-01 Procedimiento para la obtencion de una composicion farmaceutica topica.

Country Status (22)

Country Link
US (1) US4808610A (es)
EP (2) EP0318522A1 (es)
JP (1) JPH0643317B2 (es)
KR (2) KR930010585B1 (es)
AT (1) ATE62815T1 (es)
AU (1) AU603837B2 (es)
CA (1) CA1294877C (es)
DE (1) DE3769568D1 (es)
DK (1) DK174790B1 (es)
ES (1) ES2038643T3 (es)
FI (1) FI100047B (es)
GR (1) GR3002086T3 (es)
HK (1) HK102593A (es)
IE (1) IE60492B1 (es)
IL (1) IL84055A (es)
MX (1) MX9203395A (es)
NO (1) NO175350C (es)
NZ (1) NZ222020A (es)
OA (1) OA09034A (es)
PH (1) PH23440A (es)
WO (1) WO1988002257A1 (es)
ZA (1) ZA877401B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3850834T2 (de) * 1987-09-23 1995-03-30 Oreal Hautbehandlungsmittel als Aerosolschaum, das Vaseline enthält.
US5223340A (en) * 1989-04-20 1993-06-29 Peach State Labs, Inc. Stain resistant polyamide fibers
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
HU213401B (en) * 1990-09-10 1997-06-30 Schering Corp Process for producing mometasone furoate monohydrate and pharmaceutical composition containing it
US6127353A (en) * 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
US5407678A (en) * 1993-09-01 1995-04-18 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Petroleum jelly cream
IL112019A (en) * 1993-12-21 2000-02-17 Schering Corp Pharmaceutical compositions for topical treatment of psoriasis
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
AU5303899A (en) * 1998-08-26 2000-03-21 Shionogi & Co., Ltd. Anti-inflammatory ointments
FR2787025B1 (fr) * 1998-12-14 2002-10-11 Oreal Composition sous forme d'emulsion h/e a forte teneur en cire et ses utilisations dans les domaines cosmetique et dermatologique
JP4784959B2 (ja) 2002-02-19 2011-10-05 Ｈｏｙａ株式会社 電界効果トランジスタ型発光素子
WO2004105686A2 (en) 2003-05-23 2004-12-09 Taro Pharmaceuticals U.S.A., Inc. Novel topical steroid cream formulations
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EP2120868A4 (en) * 2007-04-11 2010-08-25 Perrigo Israel Phamaceuticals LOW-DOSED MOMETASON FORMULATIONS
US20080311058A1 (en) * 2007-06-18 2008-12-18 Connopco, Inc., D/B/A Unilever Stable high internal phase emulsions and compositions comprising the same
MX2010002592A (es) * 2007-09-10 2010-03-30 Glenmark Pharmaceuticals Ltd Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.
US20090082318A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched mometasone
AU2009310634B2 (en) * 2008-10-30 2013-05-09 Ego Pharmaceuticals Pty Ltd Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
RU2396081C1 (ru) * 2008-12-29 2010-08-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения дерматозов, поддающихся глюкокортикостероидной терапии, и способ ее получения
ES2547556T3 (es) 2009-05-12 2015-10-07 Galenica Ab Emulsión de aceite en agua de mometasona y propilenglicol
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate
US20110305649A1 (en) * 2010-06-14 2011-12-15 Conopco, Inc., D/B/A Unilever High Humectant High Internal Phase Emulsion
US8821839B2 (en) 2010-10-22 2014-09-02 Conopco, Inc. Compositions and methods for imparting a sunless tan with a vicinal diamine
US8398959B2 (en) 2010-12-06 2013-03-19 Conopco, Inc. Compositions and methods for imparting a sunless tan with functionalized adjuvants
US8961942B2 (en) 2011-12-13 2015-02-24 Conopco, Inc. Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
RU2548764C2 (ru) * 2013-01-25 2015-04-20 Открытое Акционерное Общество "Татхимфармпрепараты" Лекарственное средство для лечения дерматозов (варианты)
US9744122B2 (en) * 2013-04-29 2017-08-29 Helene Bertrand Topical formulation for pain relief
JP2015196663A (ja) * 2014-04-01 2015-11-09 ロレアル ナノ又はマイクロエマルションの形態の組成物
FR3039399B1 (fr) * 2015-07-31 2018-08-24 Idl International Drug Licensing Creme pour l'admnistration de steroides et son procede de preparation
MX2023002086A (es) * 2020-08-20 2023-03-15 Pfizer Formulaciones topicas estables de 1(r)-4-(5-(4-metoxi-3-propoxifen il)piridin-3-il)-1,2-oxaborolan-2-ol.
CN120500342A (zh) 2022-12-20 2025-08-15 格林尼卡皮肤股份公司 用于局部皮肤治疗的新的组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048310A (en) * 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid formulation in form of lotion or cream
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
US4124707A (en) * 1976-12-22 1978-11-07 Schering Corporation 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor
US4083974A (en) * 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
US4201778A (en) * 1977-11-08 1980-05-06 Schering Corporation 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates
US4267173A (en) * 1979-11-05 1981-05-12 Schering Corporation Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
JPS59137408A (ja) * 1983-01-27 1984-08-07 Taisho Pharmaceut Co Ltd 軟膏
US4489071A (en) * 1983-12-09 1984-12-18 Schering Corporation Betamethasone dipropionate cream

Also Published As

Publication number Publication date
ATE62815T1 (de) 1991-05-15
PH23440A (en) 1989-08-07
EP0318522A1 (en) 1989-06-07
KR880701555A (ko) 1988-11-03
FI891552A0 (fi) 1989-03-31
NZ222020A (en) 1990-03-27
NO882417D0 (no) 1988-06-01
HK102593A (en) 1993-10-08
DK295088D0 (da) 1988-05-31
AU8071287A (en) 1988-04-21
EP0262681A1 (en) 1988-04-06
OA09034A (en) 1991-03-31
IL84055A (en) 1991-09-16
JPH02500976A (ja) 1990-04-05
EP0262681B1 (en) 1991-04-24
DK295088A (da) 1988-05-31
KR930010585B1 (ko) 1993-10-30
WO1988002257A1 (en) 1988-04-07
ZA877401B (en) 1988-05-25
NO175350C (no) 1994-10-05
AU603837B2 (en) 1990-11-29
JPH0643317B2 (ja) 1994-06-08
IE60492B1 (en) 1994-07-27
DK174790B1 (da) 2003-11-17
FI891552L (fi) 1989-03-31
IE872633L (en) 1988-04-02
FI100047B (fi) 1997-09-15
NO175350B (no) 1994-06-27
GR3002086T3 (en) 1992-12-30
IL84055A0 (en) 1988-03-31
NO882417L (no) 1988-06-01
MX9203395A (es) 1992-07-01
CA1294877C (en) 1992-01-28
US4808610A (en) 1989-02-28
DE3769568D1 (de) 1991-05-29

Similar Documents

Publication Publication Date Title
ES2038643T3 (es) Procedimiento para la obtencion de una composicion farmaceutica topica.
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
EP0206291A3 (en) Sprayable pharmaceutical preparation for topical application
JO1502B1 (en) New pharmacy vehicles
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
ES2065701T3 (es) Furoato de mometasona monohidrato, procedimiento para fabricar el mismo y composiciones farmaceuticas.
ES2159382T3 (es) Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones.
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
ES2171525T3 (es) Composiciones farmaceuticas para uso topico conteniendo acido (s)-2-(4-isobutilfenil)propionico.
AR021921A1 (es) Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos y budesonido.
SE8600658D0 (sv) Novel composition of matter
ES2038606T3 (es) Una composicion para la preparacion extemporanea de formulaciones destinadas a aplicaciones topicas para uso farmaceutico y cosmetico.
AU530678B2 (en) Phosphono-hydroxy-acetic acid
GB2021409A (en) Pharmaceutical composition
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
AR009322A1 (es) Nuevas aril-piridazinas
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
ES2087178T3 (es) Disulfato de ws7622a, procedimiento para su preparacion y su uso.
ATE206048T1 (de) Zur topischen applikation bestimmte diclofenac- lösung
ES2043093T3 (es) Composicion para uso cosmetico o farmaceutico.
KR960700703A (ko) 안정한 미코페놀산 함유 피부 외용제 조성물(stable mycophenolic acid-containing composition for epidermic application)
SE8700829L (sv) Farmaceutisk komposition
SE9004076D0 (sv) Anvaendning av 10-acetyl-1,8,9-triacetoxi-antracen som antiinflammatoriskst medel vid framstaellning av farmaceutiska och kosmetiska kompositioner
SV1978002544A (es) Derivados de la everninomicina y su preparacion

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 262681

Country of ref document: ES